Navigation Links
Insmed Announces First Quarter 2008 Financial Results
Date:5/8/2008

speak only as of the date of this release. We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.

Investor Relations Contact:

Brian Ritchie - FD

212-850-5683

brian.ritchie@fd.com

Corporate Communications Contact:

John Procter - Gibraltar Associates

202-879-5808

jprocter@gibraltar-llc.com

INSMED INCORPORATED

Consolidated Balance Sheets

(in thousands, except share and per share data)

(unaudited)

March 31, December 31,

2008 2007

Assets

Current assets:

Cash, cash equivalents and short-term

investments $12,030 $16,479

Accounts receivable, net 327 250

Prepaid expenses 110 244

Total current assets 12,467 16,973

Long-term assets:

Restricted cash - long term 2,095 2,095

Investments 108 258

Deferred financing costs, net 142 170

Property and equipment, net - 4

Total long-term assets 2,345 2,527

Total assets $14,812 $19,500

Liabilities and stockholders' equity

Current liabilities:

Accounts payable $804 $904

'/>"/>
SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Insmed Appoints Dennis M. Lanfear to Board Of Directors
2. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
3. Insmed to Appeal Delisting Notification From Nasdaq
4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
5. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
6. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
7. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
8. Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
9. Insmed Announces Additional Information in Compliance With NASDAQ Rules
10. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
11. Insmed to Present at CBI Follow-On Biologics Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...l/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO...r ended September 30, 2009. The Company,s financia... ,, Third Quarter 2009 ,, The Company repo... the third quarter of 2009 as compared to a net lo...arter of 2008. ,, Net sales were $5.0 million ...
(Date:11/5/2009)...rstCall/ -- Cepheid (Nasdaq: CPHD ) today announc...lowing investor conferences, and invited investors...redit Suisse Healthcare Conference, Phoenix, AZ, ....m. Mountain Time, NASDAQ OMX 23r... Tuesday, 1 December, 2009 at 10.45 a.m. Greenwi...
(Date:11/5/2009)...ire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX ), ...tor-based technologies to discover novel flavor in...upply industries, today provided a corporate updat...rter ended September 30, 2009. Revenues were $4.2...o $4.0 million for the third quarter of 2008, an i...
(Date:11/5/2009)...ineSmith Partners has signed an initial agreement ...d that mimics the structure of natural cancellous ...products by SpineSmith,s Research and Development ...fold represents a significant advancement in techn...for the delivery of adult stem cells for skeletal ...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7Cepheid to Webcast Upcoming Financial Presentations 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
...Inc. (the "Company" or "CTI") (Nasdaq and MTA: CTI...ed Dutch Auction" tender offer (the "Exchange Offe...er to exchange shares of its common stock, no par ...ate of up to $89.2 million principal amount of the...otes (the "Notes"): , , , , 4% Converti...
...re ALS Community to Join a Nationwide Network of I... 18 The ALS Therapy Development Institute (ALS TD...ional initiative designed to increase the awarenes...lerosis), otherwise known as Lou Gehrig,s disease....her three undoubtedly American activities on July ...
...ilip Cohen,s groundbreaking research into new drug...ion at BIO 2009 , , ATLANTA, May 18 At this y...tlanta, Scotland will showcase the commercial succ...rmaceutical and biotech companies, as well as majo...overy, translational medicine, medical technology ...
Other Biology Technology:Cell Therapeutics Amends 'Modified Dutch Auction' Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes 2Cell Therapeutics Amends 'Modified Dutch Auction' Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes 3Cell Therapeutics Amends 'Modified Dutch Auction' Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes 4Cell Therapeutics Amends 'Modified Dutch Auction' Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes 5Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States 2Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States 3Scotland Highlights New Partnerships and Cutting-Edge Drug Discovery Research 2Scotland Highlights New Partnerships and Cutting-Edge Drug Discovery Research 3
(Date:11/4/2009)...swire/ -- What,s the cost of saving a teenage life...ulting from prescription medication abuse, there,s...er, may be unaware that the lock-boxes they,ve ins...king timebomb of prescription drugs. That,s why ME...ical supplies, has formed an exclusive partnership...
(Date:11/4/2009)...RNewswire/ -- GenVault Corporation (Carlsbad, CA) ...as joined its Board of Directors. Dr. Brody, the ...ute, is an acclaimed physician-scientist and unive..., Dr. Brody served as president of The Johns Hopki...demy of Engineering and the Institute of Medicine,...
(Date:11/3/2009)...report published in a recent issue of HortTechnol...amined the effects of covering orchard floors with...anopy light distribution, orchard temperature, and...ng Extenday and Solarmate films installed 5 weeks ...Gala, apples. The research showed that the use of ...
Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Reflective film can boost profits for apple growers 2After Neuroblastoma Chronic Problems Often Await 53387 1District of Columbia Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 53383 1District of Columbia Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 53383 2Chindex International Inc to Report First Quarter Fiscal 2010 Financial Results 53379 1Chindex International Inc to Report First Quarter Fiscal 2010 Financial Results 53379 2
...thwestern University have pinpointed a brain area ...ting speculation over the purpose of sleep and its...aper to be published June 8 by the journal Nature,... neurobiology and physiology, shows that the so-ca...ation in the fruitfly Drosophila melanogaster. (In...
...or women who are extremely obese may be underestim...revalence of hypertension, diabetes, and high chol...ording to a study in the July 5 issue of JAMA. , O... on body mass index (BMI) of at least 30. BMI is c... in meters squared. However, three categories of o...
...ls, prized for their astonishing ability to appare...acquire their identities in part by interacting wi... of the body in a laboratory dish, University of F... of embryonic stem cell development, researchers w...swer one of the most fundamental questions in scie...
Other Biology News:Higher levels of obesity associated with greater health risks 2Higher levels of obesity associated with greater health risks 3Birds going extinct faster due to human activities 2Birds going extinct faster due to human activities 3
... is used to quantitate double-stranded DNA (dsDNA)...in. With this kit, DNA is stained with Hoechst 332... other fluorometer. The kit quantitates dsDNA in t...d contains Hoechst 33258, calf thymus DNA standard...
...rise-scale sequence analysis software with the DeC...tensive bioinformatics analyses. With DeCypher, yo...p: BLAST 300,000 ESTs vs NCBI NT database in unde...nomic DNA Use HMM analysis to compare 100,000 se...
MagNA Pure LC Instrument from Roche Applied Science
Mouse Anti-Human ALS2CR8 Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: